Webinar: New Advancements in the Testing and Treatment of HIV
Healthcare News | 2013-11-27
With nearly 2.5 million new infections worldwide each year1 the risk of HIV remains significant. For clinicians and blood banks, the need to control infection and increase transfusion safety further underscore the demand for enhanced HIV diagnostics. Today, a new antigen/antibody assay can support both early detection of HIV in clinical settings and the specificity requirements of blood banks.
Immunoassays that detect HIV antigen (p24) as well as HIV antibodies allow earlier detection of HIV infection when compared to their antibody-only counterparts. This has led to the European Union recommending HIV combo tests as the standard screening technique. However, adoption of combo tests has been hindered by their perceived decrease in specificity when compared to antibody-only assays. Learn how these new diagnostic tools provide the sensitivity required for early detection and the specificity required in blood banks.
Enhanced HIV Diagnostics:
New Advancements in the Testing and Treatment of HIV